About

ST-segment elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality. Challenges in diagnosis remain due to variability in ECG presentation, conditions with similar presentations, variability in the electrical manifestation of ST-segment elevation on ECG, and systems issues with access to rapid diagnosis that can make this diagnosis challenging.

Given the significant morbidity and mortality associated with STEMI, there has been a push to improve the timely diagnosis of STEMI to ensure patients receive therapy faster. However, there remain challenges in diagnosis.

Articles

Preventive Percutaneous Coronary Intervention in ST-elevation Myocardial Infarction – The Primacy of Randomised Trials

Citation:

Interventional Cardiology Review 2015;10(1):32–4

Contemporary Antiplatelet Strategies in the Treatment of STEMI using Primary Percutaneous Coronary Intervention

Citation:

Interventional Cardiology Review 2015;10(1):26–31

Current Antithrombotic Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions

Citation:

Interventional Cardiology Review 2014;9(2):94–101

Use of Thrombectomy Devices in Primary Percutaneous Interventions for ST-elevation Myocardial Infarction - An Update

Citation:

Interventional Cardiology Review 2014;9(2):102–7